These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16266989)

  • 1. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling.
    Hodgson JG; Malek T; Bornstein S; Hariono S; Ginzinger DG; Muller WJ; Gray JW
    Cancer Res; 2005 Nov; 65(21):9695-704. PubMed ID: 16266989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression.
    Ling C; Su VM; Zuo D; Muller WJ
    Cancer Discov; 2012 Jan; 2(1):68-81. PubMed ID: 22585169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
    Andrechek ER; Muller WJ
    Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.
    Deblois G; Chahrour G; Perry MC; Sylvain-Drolet G; Muller WJ; Giguère V
    Cancer Res; 2010 Dec; 70(24):10277-87. PubMed ID: 20961995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu.
    Montagna C; Andrechek ER; Padilla-Nash H; Muller WJ; Ried T
    Oncogene; 2002 Jan; 21(6):890-8. PubMed ID: 11840334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
    Guo W; Pylayeva Y; Pepe A; Yoshioka T; Muller WJ; Inghirami G; Giancotti FG
    Cell; 2006 Aug; 126(3):489-502. PubMed ID: 16901783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
    Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
    Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M; Neel BG
    Cancer Res; 2007 Mar; 67(6):2420-4. PubMed ID: 17347513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome profiling of ERBB2-amplified breast cancers.
    Sircoulomb F; Bekhouche I; Finetti P; Adélaïde J; Ben Hamida A; Bonansea J; Raynaud S; Innocenti C; Charafe-Jauffret E; Tarpin C; Ben Ayed F; Viens P; Jacquemier J; Bertucci F; Birnbaum D; Chaffanet M
    BMC Cancer; 2010 Oct; 10():539. PubMed ID: 20932292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Raghuram N; Temel EI; Kawamata T; Kozma KJ; Loch AJ; Wang W; Adams JR; Muller WJ; Egan SE
    Breast Cancer Res; 2024 May; 26(1):86. PubMed ID: 38807216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
    Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
    Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
    Ordonez LD; Melchor L; Greenow KR; Kendrick H; Tornillo G; Bradford J; Giles P; Smalley MJ
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34003256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
    Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.